Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by icecubeon Jun 23, 2015 1:12am

48 Views

Post# 23858053

RE:RE:RE:RE:Look at all the promoting going on here...

truthseeker2012 wrote: Read styless posts he bought at $13.50 so how could he be saying it was going down since $15.00? Styless was bashing this stock when it was $3.00, $4.00 $5.00 $6.00 $7.00 $8.00 etc etc.

Everyone needs a hobby.

Just use the ignore button if you don't like his hobby.

Bullboard Posts

Canadian psychedelic stock to supply MDMA to Yale